The article says that MAPS offered to donate $5 million over 5 years to UMass Amherst for the marijuana production facility. Actually, $5 million over 5 years is MAPS's estimate for the cost of a serious medical marijuana drug development research effort designed to provide FDA with proof of safety and efficacy. The first year costs for the UMass Amherst facility, if approved, are estimated to be in the range of $500,000.